(CIDRAP News) – With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs.
(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.
(CIDRAP News) A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.
(CIDRAP News) The US government needs much closer collaboration with private industrylike the arrangements used in building aircraft carriers and putting men on the moonin order to improve the nation's medical defenses against biological, chemical, radiological, and nuclear threats, says a report from a federal advisory panel.
(CIDRAP News) The president of the Association of Public Health Laboratories (APHL) complained to Congress last week that the federal program that monitors the air for dangerous pathogens in major cities is a heavy burden on state and local laboratories.
(CIDRAP News) – The US Department of Health and Human Services (HHS) recently unveiled its plan for developing and buying medical countermeasures against a range of biological, chemical, and other threats, with new anthrax and smallpox vaccines among the near-term priorities.
(CIDRAP News) Soon after the terrorist attacks of 2001, Congress approved emergency funds to teach hospital staffs how to recognize and respond to bioterrorism attacks, and today the US Centers for Disease Control and Prevention (CDC) released its first report on those efforts.
(CIDRAP News) The Centers for Disease Control and Prevention (CDC), which recently reconstructed the 1918 pandemic influenza virus for research purposes, has classified the virus as a "select agent," imposing special rules on groups that handle it.
Editor's note: This story was revised shortly after publication to reflect corrections issued by the National Institute of Allergy and Infectious Diseases on May 10. The corrections pertain to the total monetary amount of the grants and to the project descriptions for XOMA (US) LLC and DVC Dynport LLC.